GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2676 - 2700** of **4050** in total

« First

‹ Prev

…

104

105

106

107

108

109

110

111

112

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgM	Patient 4	12	mild	G72739GY	97
IgM	Patient 1	22	moderate	G51175PR	96
IgG	Patient 2	24	mild	G22768VO	96
IgM	Patient 4	12	mild	G86541PE	96
IgG	Patient 2	24	mild	G54064FW	95
IgM	Patient 2	15	mild	G52880ZN	95
IgM	Patient 2	15	mild	G65889KE	95
IgM	Patient 2	24	mild	G52880ZN	95
IgM	Patient 1	6	moderate	G36544AC	95
IgM	Patient 2	24	mild	G96557TJ	95
IgG	Patient 3	11	mild	G10133VD	95
IgM	Patient 3	-180	mild	G18057VI	95
IgM	Patient 3	-180	mild	G29857RC	95
IgM	Patient 3	4	mild	G57449OF	95
IgG	Patient 4	12	mild	G36544AC	95
IgM	Patient 2	15	mild	G32611KT	94
IgM	Patient 2	15	mild	G96865DJ	94
IgM	Patient 2	24	mild	G40696TO	94
IgG	Patient 2	3	mild	G47548GA	94
IgG	Patient 2	3	mild	G72424VO	94
IgM	Patient 3	-180	mild	G00052MO	94
IgM	Patient 3	-180	mild	G17390SF	94
IgM	Patient 3	-180	mild	G61751GZ	94
IgG	Patient 3	11	mild	G43534QA	94
IgM	Patient 3	11	mild	G24432YB	94